Metropolis Healthcare Limited (METROPOLIS.BO)
INR 2132.05
(0.01%)
INR 2132.05
(0.01%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.62 Billion | 2.47 Billion | 2.53 Billion | 2.49 Billion | 2.15 Billion | 901.5 Million |
| Net Income | 1.27 Billion | 1.87 Billion | 2.93 Billion | 2.44 Billion | 1.68 Billion | 1.86 Billion |
| Depreciation & Amortization | 944.67 Million | 892.15 Million | 632.22 Million | 459.44 Million | 392.67 Million | 200.66 Million |
| Deferred income taxes | - | -581.18 Million | -1 Billion | -322 Million | -241.41 Million | -636.35 Million |
| Stock-based compensation | 14.16 Million | 2.85 Million | 68.57 Million | 77.87 Million | 7.23 Million | 8.84 Million |
| Change in working capital | 54.52 Million | 71.1 Million | -163.98 Million | -153.06 Million | 279.73 Million | -507.81 Million |
| Other non-cash items | 2.24 Billion | 210.93 Million | 71.73 Million | -15.19 Million | 24.45 Million | -29.34 Million |
| Investing Cash Flow | -915.77 Million | 467.94 Million | -7.37 Billion | 617.01 Million | -1.04 Billion | 353.42 Million |
| Investments in PPE | -637.61 Million | -526.33 Million | -306.62 Million | -282.72 Million | -362.06 Million | -237.43 Million |
| Acquisitions | -6.5 Million | -4.5 Million | -6.37 Billion | -53.94 Million | -123.79 Million | -32.34 Million |
| Investment purchases | -1.57 Billion | -2.55 Billion | -800.43 Million | 159.11 Million | -852.91 Million | -562.5 Million |
| Sales/Maturities of investments | 1.3 Billion | 3.48 Billion | 175.7 Million | 848.52 Million | 246.54 Million | 1.15 Billion |
| Other Investing Activities | -6.5 Million | 66.5 Million | -65.09 Million | -53.94 Million | 43.92 Million | 32.89 Million |
| Financing Cash Flow | -1.77 Billion | -2.92 Billion | 1.62 Billion | -326.9 Million | -553.23 Million | -1.18 Billion |
| Debt repayment | -790.52 Million | -1.78 Billion | -3.41 Billion | -351 Thousand | -177.44 Million | -1.63 Million |
| Dividends payments | -204.96 Million | -409.68 Million | -409.37 Million | -408.93 Million | -483.94 Million | -665.36 Million |
| Common Stock Repurchased | - | - | 5.43 Billion | -252.56 Million | -210.77 Million | -35.54 Million |
| Common Stock Issuance | 34 Thousand | 1.83 Million | 19.74 Million | 343.17 Million | 318.92 Million | 25.72 Million |
| Other Financing Activities | -224.76 Million | -726.77 Million | -33 Thousand | -8.23 Million | -82.51 Million | -504.65 Million |
| Accounts receivables | -123.69 Million | 158.26 Million | 116.84 Million | -138.94 Million | -242.01 Million | -461.98 Million |
| Accounts payables | 57 Million | -53.12 Million | -165.07 Million | 234.41 Million | 316.32 Million | 75.11 Million |
| Inventory | 58.97 Million | 65.15 Million | -79.37 Million | -161.47 Million | 17.01 Million | -49.15 Million |
| Other working capital | 62.23 Million | -99.18 Million | -36.38 Million | -87.06 Million | 188.4 Million | -71.79 Million |
| Cash at beginning of period | 693.08 Million | 659.8 Million | 3.86 Billion | 1.07 Billion | 513.71 Million | 434.67 Million |
| Cash at end of period | 712.15 Million | 688.33 Million | 659.8 Million | 3.86 Billion | 1.07 Billion | 513.71 Million |
| Capital Expenditure | -637.61 Million | -526.33 Million | -306.62 Million | -282.72 Million | -362.06 Million | -237.43 Million |
| Effect of forex changes on cash | 8.34 Million | 12.97 Million | -13.63 Million | 13.79 Million | 9.56 Million | 5.56 Million |
| Net cash flow / Change in cash | 19.06 Million | 28.52 Million | -3.2 Billion | 2.79 Billion | 558.03 Million | 79.03 Million |
| Free Cash Flow | 1.98 Billion | 1.94 Billion | 2.22 Billion | 2.2 Billion | 1.78 Billion | 664.07 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 379.47 Million | 1.27 Billion | 364.06 Million | 271.58 Million | 354.54 Million | 287.96 Million |
| Depreciation & Amortization | - | 944.67 Million | - | 249.9 Million | 222.39 Million | 208.2 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 14.16 Million | 14.16 Million | - | - | - |
| Change in working capital | - | 54.52 Million | - | - | - | - |
| Other non-cash items | -379.47 Million | 2.24 Billion | -378.23 Million | -271.58 Million | -354.54 Million | -287.96 Million |
| Investing Cash Flow | - | -915.77 Million | - | - | - | - |
| Investments in PPE | - | -637.61 Million | - | - | - | - |
| Acquisitions | - | -6.5 Million | - | - | - | - |
| Investment purchases | - | -1.57 Billion | - | - | - | - |
| Sales/Maturities of investments | - | 1.3 Billion | - | - | - | - |
| Other Investing Activities | - | -6.5 Million | - | - | - | - |
| Financing Cash Flow | - | -1.77 Billion | - | - | - | - |
| Debt repayment | - | -790.52 Million | - | - | - | - |
| Dividends payments | - | -204.96 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 34 Thousand | - | - | - | - |
| Other Financing Activities | - | -224.76 Million | - | - | - | - |
| Accounts receivables | - | -123.69 Million | - | - | - | - |
| Accounts payables | - | 57 Million | - | - | - | - |
| Inventory | - | 58.97 Million | - | - | - | - |
| Other working capital | - | 62.23 Million | - | - | - | - |
| Cash at beginning of period | - | 693.08 Million | - | 509.3 Million | 154.75 Million | 693.08 Million |
| Cash at end of period | - | 712.15 Million | - | 271.58 Million | 509.3 Million | 287.96 Million |
| Capital Expenditure | - | -637.61 Million | - | - | - | - |
| Effect of forex changes on cash | - | 8.34 Million | - | - | - | - |
| Net cash flow / Change in cash | - | 19.06 Million | - | -237.71 Million | 354.54 Million | -405.12 Million |
| Free Cash Flow | - | 1.98 Billion | - | 271.58 Million | 354.54 Million | 287.96 Million |
6236
CKX
ZZ-B
PREC
ATLX
TATACHEM